Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver Cirrhosis
1 other identifier
observational
100
1 country
1
Brief Summary
Portal hypertension is a common complication of liver cirrhosis that can lead to development of esophageal varices (EV). They are abnormally dilated veins within the wall of the esophagus that lead to haemorrhage (1). Majority of patients with cirrhosis will develop EV at some point, and about third of these patients will have at least one bleeding episode because of rupture of a varix . For this reason, screening endoscopy for detection of the presence of EV should be part of the diagnostic work-up in patients with cirrhosis. This is a very important preventive step for identification of those patients with variceal bleeding risk and furthermore, identification of patients in urgent need for prophylactic treatment. All guidelines stress on screening endoscopy for early detection of EV in cirrhotic patients with portal hypertension. However this approach is limited by its invasiveness and cost effectiveness issues of screening endoscopy .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 27, 2015
CompletedFirst Posted
Study publicly available on registry
December 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedJune 20, 2017
June 1, 2017
4.7 years
November 27, 2015
June 17, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients with esophageal varices and have low platelet count
1 year
Interventions
Correlation of esophageal varices with platelet count
Eligibility Criteria
A total of 110 cirrhotic patients were included
You may qualify if:
- Diagnosis of cirrhosis based on history, physical examination, laboratory tests, ultrasound scans and liver biopsy in some occasion.
You may not qualify if:
- Hepatocellular carcinoma.
- Portal vein thrombosis.
- Parenteral drug addiction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sherief Abd-Elsalamlead
- Tanta Universitycollaborator
Study Sites (1)
Tropical medicine dept.-Tanta university hospital
Tanta, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sherief Abd-Elsalam
Tanta university hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Hepatology and gastroenterology dept., tanta university, M.D., Principle investigator
Study Record Dates
First Submitted
November 27, 2015
First Posted
December 3, 2015
Study Start
January 1, 2015
Primary Completion
September 1, 2019
Study Completion
October 1, 2019
Last Updated
June 20, 2017
Record last verified: 2017-06